Our findings further highlight adaptive activation of VEGF signaling in high-risk clear cell renal cell carcinoma (ccRCC), potentially driving angiogenic or vascular remodeling responses to inflammatory and immune stressors. This evidence concerns the gene VEGFA and clear cell renal carcinoma.